Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

about

Inhibition of v-rel-Induced Oncogenesis through microRNA Targeting.

P2860

Q54219136-C9E247F7-4607-4662-83DF-F9FF2D1EC471

P2860

Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

Item

http://www.wikidata.org/entity/Q48505142

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

@en

Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

@nl

type

Item

label

Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

@en

Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

@nl

prefLabel

Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

@en

Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

@nl

P1476

Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

@en

P2093

Chunyi Xue

http://www.w3.org/2001/XMLSchema#string

Liangliang He

http://www.w3.org/2001/XMLSchema#string

Yongchang Cao

http://www.w3.org/2001/XMLSchema#string

Yuan Fang

http://www.w3.org/2001/XMLSchema#string

Yun Zhang

http://www.w3.org/2001/XMLSchema#string

Yuqi Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs

The role of RNAi and microRNAs in animal virus replication and antiviral immunity

The global health burden of infection-associated cancers in the year 2002

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

HIV infection and the risk of cancers with and without a known infectious cause.

Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas.

Marek's disease virus: from miasma to model.

MicroRNA sponges: progress and possibilities.

Marek's disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway.

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

P304

3842-3852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23379

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29423087

http://www.w3.org/2001/XMLSchema#string

P921

RNA design

P932

5790504

http://www.w3.org/2001/XMLSchema#string

Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

about

P2860

P2860

Design of miRNA sponges for MDV-1 as a therapeutic strategy against lymphomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932